Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00171678 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis
A Phase 3 study of Osteearthritis, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT00171678 is a Phase 3 study of Osteearthritis that has completed, run by Novartis. The registered enrollment target is 480 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00171678, a Phase 3 study of Osteearthritis, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.
Conditions Studied
Interventions
- DRUG Diclofenac Topical Sodium Gel 1%
Study Locations (1)
New Jersey
- Novartis Consumer Health Inc. - Parsippany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00171678
The ClinicalTrials.gov registry entry for NCT00171678 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteearthritis appearing as the primary indexed condition, and to 1 intervention - of which Diclofenac Topical Sodium Gel 1% is the first listed.
NCT00171678 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT00171678 about?
NCT00171678 is a clinical study titled "Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis". This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.
What is the current status of trial NCT00171678?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2004-10. Estimated completion is 2005-08.
What conditions does trial NCT00171678 study?
This clinical trial studies the following conditions: Osteearthritis.
What interventions are being tested in trial NCT00171678?
The interventions under investigation include: Diclofenac Topical Sodium Gel 1% (DRUG).
Who is sponsoring clinical trial NCT00171678?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00171678 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.